Personal MedSystems | CardioSecur

Personal MedSystems | CardioSecur

Personal MedSystems is a pioneer in digital health, founded in 2008 and headquartered in Germany. The company has developed the CardioSecur product portfolio, with a focus on mobile 12-lead ECG technologies, enabling patients and physicians to perform instant heart checks wherever they are. The innovative CardioSecur is the first and only mobile 22-lead ECG system with only 4 electrodes, providing an easy-to-use personalized heart check for iPad/iPhone/iPod touch, allowing patients to gain certainty about their hearts' activity at all times.

Since their latest Series B investment of €5.00M at 23 January 2017, Personal MedSystems has garnered support from notable investors such as KPN Ventures, NRW BANK, and SGHF. Their breakthrough technology offers instant evaluation of ischemic and rhythmic disorders, providing direct recommendations for swift and appropriate patient actions. Physicians also have the unique opportunity to make precise diagnoses based on 22-lead ECG data, addressing an often insufficiently screened area of cardiac health.

With its slogan "Knows your heart," Personal MedSystems aims to revolutionize mobile healthcare delivery, providing individuals and healthcare providers with the tools to monitor and address heart health concerns in a convenient and effective manner.